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Summary 
Normal  skin  is  permeable  to  low  molecular  hydrophobic  substances,  including  allergenic 
chemicals.  Whereas  such  foreign  matter appears  to  enter  the  skin  naturally,  it rarely induces 
contact hypersensitivity. This suggests that immunological tolerance would be the normal state 
of affairs. In search of a suitable model, we painted picryl chloride or oxazolone once or repeat- 
edly on normal skin of BALB/c or C57B1/6 mice and found subsensitizing doses to be tolero- 
genic. The most effective doses in inducing tolerance were doses between those at the point of 
inflection from no responses to threshold sensitivity. But even doses three orders of magnitude 
lower than these suppressed subsequent  sensitization if applied repeatedly.  C57B1/6  mice (low 
responders)  were  consistently  easier  to  make  tolerant  than  BALB/c  mice  (high  responders). 
The tolerant state established by a single painting was found to be fully developed at 48 h  after 
initiation  and long-lasting  (> 14 d).  It could be adoptively transferred by intravenous injection 
of total spleen cells (SC), lymph node cells (LNC),  or purified T  cells and shown to be hapten 
specific. Pretreatment with cyclophosphamide  (Cy) prevented tolerization.  The T  cells capable 
of transferring suppressive activity were found to be generated irrespective of the dose applied. 
On day 2 after painting,  tolerance could be transferred with LNC from both tolerant and sen- 
sitized animals.  On day 5, however, only cells from tolerant donors transferred tolerance.  But 
by action  of Cy,  suppression  was  shown  to be part of every sensitization,  although  masked. 
Production  ofhapten-specific antibodies was suppressed as well.  Through depletion by mono- 
clonal antibody in vitro the T  suppressor cells were shown to belong to the murine CD8 + sub- 
set (Lyt2+).  Upon restimulation  in vitro by haptenized  and irradiated  normal SC,  LNC  from 
tolerant donors produced predominantly interleukin  (IL)-4, IL-5, and IL-10. In contrast, LNC 
from sensitized  donors  produced  preferentially  IL-2 and  interferon-"/.  Thus  we  demonstrate 
that painting subsensitizing doses of contact sensitizers on normal murine skin generates CD8 + 
Th2-1ike cells that give rise to hapten-specific tolerance.  The model may have broader signifi- 
cance and apply to other species, including humans. 
A 
nimal  models  of contact  hypersensitivity  (CHS) t  to 
haptenic molecules (1) have contributed greatly to un- 
derstanding  the  mechanisms  that  govern  allergic  contact 
dermatitis.  This major skin disease causes considerable  dis- 
tress  to  affected patients  and,  in  the  form  of occupational 
contact  dermatitis,  immense  costs  for  society  (2).  Even 
now,  the  allergen-specific  hypersensitive state,  once estab- 
lished,  cannot be reversed clinically, making it necessary to 
avoid forever the causative agent. 
~Abbreviations used in this  paper: CHS, contact hypersensitivity; Cy, cyclo- 
phosphamide; LNC, lymph node cells; Ox, oxazolone; PC1, picryl chlo- 
ride; SC, spleen cells; TNBS, 2,4,6-trinitrobenzenesulfonic acid. 
This paper is dedicated to Dr. Merrill W. Chase on the occasion of his 
90th birthday. 
Parts of this work were presented at the annual meeting of the "Ar- 
beitsgemeinschaft flir Dermatologische Forschung" in Wiirzburg, Ger- 
many on 18-20 November 1994 (1995. Arch. Dermatol. Res. 287:397). 
However, it is known  that entrance  through  the skin of 
haptenic  molecules  generates  not  only  T  lymphocytes  ef- 
fecting  inflammatory  symptoms  in  sensitized  skin  but  in- 
duces  as  well  T  cells  that  exert  anti-inflanunatory  effects 
(3).  These latter cells generally have been termed suppres- 
sor cells (4), and upon selective stimulation  they mediate a 
state  of hapten-specific  tolerance  (5-8).  They were  shown 
to  negatively regulate  the  immune  response  in  an  unsus- 
pected  complex  manner  with  several  sets  of T  cells  in- 
volved, each having characteristic surface markers and pro- 
ducing  specific  factors  (9).  It  was  proposed  that  in  all 
murine systems, T  cell suppression proceeds by a single ma- 
jor pathway involving the sequential interactions of three T 
cell subsets that have been termed Ts~, Ts2, and Ts  3 (10). 
More  recently,  the  T  suppressor  cascade  as  outlined 
above has been replaced by a simpler model of suppression 
(11)  based  on  the  finding  that  not  only  CD4 +  but  also 
CD8 §  T  lymphocytes  separate  on  appropriate  stimulation 
759  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/03/759/10  $2.00 
Volume 183  March 1996  759-768 into  functional subsets  termed  type  1  and  type  2.  These 
subsets  are  defined  by  the  pattern  of lymphokines  pro- 
duced, with IL-2 and IFN-~/being the predominant cyto- 
kines of the type 1 pattern and IL-4, IL-5, and IL-10 those 
of the type 2 pattern. The concept has been worked out in 
CD4 + cells first (12,  13), but there is recent evidence that it 
applies as well to the CD8 + phenotype (14). Most interest- 
ing in this respect is the finding that naive CD8 §  T  cells 
can be induced in vitro to secrete the helper cytokine IL-4 
(15). Moreover, CD8 § T  cells were shown in the presence 
of IL-4 to switch to B  cell help and the production of Th2 
cytokines,  but  to  lose  cytotoxic  activity  (16).  Although 
such CD8 + Th2-like cells also have been shown to exist in 
mice and humans  (17-22) it is still considered a  "challeng- 
ing task" to demonstrate that antigen-specific CD8 + Th2- 
like cells can be derived directly in vivo (23). 
Immunological  tolerance  is  known  to  be  the  classical 
field of activity for  suppressor  T  cells.  We  hypothesized 
that CD8 + Th2-like cells could play a functional role there. 
To  test this hypothesis, we induced tolerance in mice by 
painting  subsensitizing  doses  of allergenic  chemicals  on 
normal skin. We  chose this particular model for two  rea- 
sons. First, the induction of tolerance by dilute amounts of 
foreign matter passing through the skin could have patho- 
physiologic significance, as it might represent a fundamen- 
tal mechanism  dealing with  the  handling of non-self that 
enters the body in small amounts by way of the skin. Sec- 
ond,  the induction of tolerance by painting nonimmuno- 
genic doses of chemical allergen on normal skin has already 
been observed fortuitously by Chase  (24)  as early as  1943. 
Later on it was shown that low doses of contact sensitizers 
applied epicutaneously indeed effect hapten-specific toler- 
ance  (25-27).  The  original observation was  subsequently 
confirmed (28), also by chance, but in mice efficacy in tol- 
erization of topical exposure to low doses still requires rig- 
orous proof. 
We found that low dose tolerance to chemical allergens 
was clearly dose dependent, hapten specific, and long-last- 
ing.  It  could  be  adoptively transferred by  cyclophospha- 
mide  (Cy)-sensitive T  cells that  also  extended  their  sup- 
pressive activity to antibody production. They were found 
to belong solely to the routine CD8 + T  cell subset. Upon 
restimulation by hapten in vitro, these cells produced pref- 
erentially helper cytokines, that is,  IL-4, IL-5, and  IL-10, 
whereas lymph node cells (LNC) from sensitized mice pro- 
duced predominantly IL-2 and IFN-~/. Thus,  we  demon- 
strate that low zone tolerance to contact allergens is medi- 
ated by CD8 + Th2-like cells. 
Materials and Methods 
Animals.  BALB/c mice and C57B1/6  mice were purchased 
from  Charles  River  (Sulzfeld,  Germany).  Animals were  main- 
tained in a temperature- and light-controlled environment with 
free  access  to  food and water.  During experiments, arrimals  of 
both sexes at 8-12 wk of age were housed singly in transparent 
Makrolan cages.  Experimental groups consisted of five or more 
animals matched for age and sex.  All mice in each experiment, 
including both  normal  and positively sensitized controls,  were 
randomized in advance with respect to cage position in the room. 
Chemicals.  Picryl chloride  (PC1; 2,4,6-trinitro-l-chloroben- 
zene), oxazolone (Ox; 4-ethoxy-methylene-2-phenyl-oxazolone), 
TNBS (2,4,6-trinitrobenzenesulfonic acid), and Cy monohydrate 
were all purchased from Sigma (Deisenhofen, Germany). 
Experimental Sensitization and Tolerization.  The  right  ear was 
used  for  sensitization and  the  left  ear  was  used  for  challenge. 
When more than one application for sensitization was desired, al- 
lergens were applied on clipped areas of abdomen or dorsum as 
required. Both allergens were dissolved in olive oil/acetone (1 : 5); 
solutions were prepared immediately before using. Volumes of 15 
0,1 each of PCI or of Ox were applied once epicutaneously by 
means of a pipette (Eppendorf-Netheler-Hinz GmbH, Hamburg, 
Germany). The single doses applied in this manner ranged from 
7.500 I~g down to 0.00045  p~g PC1 and from 1.000  p~g down to 
0.0075  ~g Ox. From dose-response curves drawn thereof, stan- 
dard doses in 15 I~1 for obtaining sensitization were found to be 
450 I~g PC1 and 750 p~g Ox, whereas standard doses to secure tol- 
erization were 4.5 Ixg PC1 and 7.5 p,g Ox, respectively. 
Double Sensitization.  Standard doses of  both PC1 and Ox were 
applied on clipped abdominal areas of the fight and left side, thus 
keeping both ears available for concurrent contact testing. 
Assessment of CHS.  On day 5 after the sensitizing application, 
45 p~g PC1 or 30 ~g Ox dissolved in 15 ~1 of the solvent were pi- 
petted on the dorsum of the left ear. Ear thickness was measured 
both  at  24  and  48  h  with  an  engineer's micrometer  (Oditest, 
Kroeplin, Schi~chtern,  Germany) and compared with ear thick- 
ness before challenge. All measurements were read blindly by K. 
Steinbrink. 
Assessment of Tolerance.  Single applications of tow doses (4.5 
p~g PC1, 7.5 ~,g Ox, and lower doses) which in previous sensitiza- 
tion experiments had been found to be subimmunogenic, were 
7 d later directly followed by standard sensitization (450  p~g PCI 
or 750 ~g Ox) on the abdominal wall; tolerance was assessed by 
just one final contact test on the left ear. 
Treatment with Cy.  Mice were injected intraperitoneally with 
Cy at a dose of 200 mg/kg in PBS 2 d before application of a sen- 
sitizing or tolerizing dose or of the solvent. 
Culture Media.  tLPMI-1640  was  supplemented with  2  mM 
glutamine,  100  U/ml penicillin, 100  p~g/ml  streptomycin, 10% 
heat-inactivated FCS (all from Gibco, Eggenstein, Germany), 5  ￿ 
10 -s M 2-ME, and 1 p~g/ml indomethacin (both from Sigma). 
Preparation of LNC, Spleen Cells, and Purified T Cells.  5 d  after 
sensitization or 2 d after the last painting of a tolerizing dose, re- 
spectively, mice were killed by ether euthanasia and spleens or 
lymph nodes were taken. LNC were obtained either from auric- 
ular, inguinal, or mesenteric lymph nodes. Single cell suspensions 
of LNC or spleen cells (SC) were prepared under aseptic condi- 
tions by mechanical disaggregation and passed through a sterile 
nylon gauze. Cells were washed three times and resuspended in 
RPMI-1640 complete. Viability was noted to be >95%, as deter- 
mined by trypan blue exclusion. Purified T  cells were prepared 
using the method of  Julius et al. (29). Briefly, LNC (10V/ml) were 
incubated in a nylon wool column for  1 h  at 37~  After two 
washings with medium, T  cells were pelleted by centrifugation 
and viability was determined by trypan blue exclusion. Enrich- 
ment ofT cells (>95.5%) was examined by FACS  |  analysis (Bec- 
ton Dickinson, Heidelberg, Germany). 
Cell Transfer Experiments.  2 d after the last painting of a toler- 
izing dose, LNC  or SC suspensions were obtained as described 
above. For adoptive transfer,  107  viable LNC  or SC  in 0.5  rnl 
RPMI-1640  were  injected intravenously into  naive  syngeneic 
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anti-L3T4 mAb (antimurine CD4,  clone GK 1.5)  or anti-Lyt2 
mAb (antimurine CD8,  clone 53.6;  both from Becton Dickin- 
son) at a final dilution of 1 : 100  for 1 h  at 4~  The cells were 
washed three times with RPMI  to remove FCS and incubated 
with magnetobeads coated with sheep anti-rat IgG (Dynal, Ham- 
burg, Germany) for 1 h at 4~  Thereafter, tubes were placed in a 
magnet  and  the  residual cells collected. The  negative-depleted 
cells were washed twice by centrifugation, and 107 cells were in- 
jected intravenously into recipients. The L3T4 and Lyt2  + nega- 
tive populations were determined by FACS  |  analysis and shown 
to contain <0.5% positive cells.  1 h after injection, animals were 
sensitized and 5 d later, they were ear challenged. 
Preparation ofHapten-modified SC  Spleens  of untreated  mice 
were excised and disaggregated into single cell suspensions.  Eryth- 
rocytes were lysed and the remaining cells washed three times in 
HBSS (Gibco). 107 cells/ml were resuspended in HBSS contain- 
ing 10 mM TNBS and incubated for 10 rain at 37~  Cells were 
washed three times with RPMI-1640  complete to remove free 
hapten. Alternatively, cells were oxazolonated by adding 10 I~1 of 
a 0.5% ethanolic solution of Ox to the SC (107/ml PBS) at 37~ 
for 10 rain. Thereafter, cells were washed three times and irradi- 
ated (2,500 rad). 
Lymphokine ELISAs.  LNC  (2  X  10  s cells/well) were incu- 
bated with 105 hapten-modified and irradiated (2,500 rad) SC us- 
ing 96-well round-bottomed microtest plates (Greiner, Fricken- 
hausen,  Germany). After 72 h of  culture in a humidified atmosphere 
of 5% CO2 at 37~  supernatants were harvested, spun at 750 g 
for 15 rain to eliminate dead debris, and frozen at -80~  ELI- 
SAs for IL-2, IL-4, IL-10, and IFN-~/were performed using sand- 
wich ELISA kits purchased from Genzyme (Ismaning, Germany). 
All protocols were completed according to the manufacturer's in- 
structions. IL-5 was quantified in a two-side sandwich ELISA as 
described previously (30). Briefly, maxisorb plates (Nunc, Wies- 
baden, Germany) were coated with 50  ~1 of 2  ~g/ml rat anti- 
mouse IL-5 antibody (clone TRFK5; Dianova, Hamburg,  Ger- 
many) and incubated overnight at 4~  Subsequently, wells were 
blocked by adding 200 ILl 10% FCS in PBS for 2 h at room tem- 
perature. Samples and standards (recombinant murine IL-5; Bier- 
mann, Bad Nauheim, Germany) were diluted in R.PMI-1640 com- 
plete and incubated for 4 h at room temperature. After washing, 
each well received 100 I~1 of 1 Ixg/ml biotinylated rat anti-mouse 
IL-5 (clone TR.KF4, Dianova). Plates were incubated for 45 min 
at room temperature followed by three washings.  Streptavidin- 
horseradish peroxidase was added at a concentration of 1 ~g/ml 
(100  ~1) and incubated at room temperature for 30 rain. Plates 
were subsequently washed 10 times, and 100 b~l substrate (ABTS, 
2,2-azino-di-3-ethylbenzthiazoline  sulfonate; Boehringer, Mann- 
heim, Germany) at a concentration of I mg/ml in 44 mM NazHPO, 
28  mM  citric acid, and 0.003%  H20 z was added. The  colored 
product was measured at a wavelength of 405  nm. Samples were 
assayed in duplicate and differences between replicate wells were 
uniformly <5% for IL-2, IL-5, and IFN-% and <10% for IL-4 
and IL-10. The sensitivities for these assays are IL-2 <10 pg/ml, 
IL-4 <1  pg/ml, IL-5 <15  Izg/ml, IL-10 <1  pg/ml, and IFN-~/ 
< 1 pg/rnl. 
ELISA for Anti-Ox and Anti-PCl Antibodies (According to (31)). 
Hapten protein conjugates were prepared for use in ELISA. Ox 
(60 mg in 0.5 ml methoxyethanol) was added slowly to 10 ml of a 
25 mg/ml solution of BSA in 0.5 sodium bicarbonate buffer. The 
mixture  was  stirred for  3  h  at  room  temperature  and  the  pH 
maintained at 8 by addition of 1 M  sodium hydroxide. Protein 
was desalted by Sephadex G-25 column chromatography (Phar- 
macia, Freiburg, Germany), dialyzed against water, lyophilized, and 
stored at -20~  For the detection of antibodies to PC1, a second 
conjugate was  similarly prepared substituting PC1  for Ox.  The 
wells of plastic microtiter plates (Nunc) were coated with 100 Izl 
(10 Ixg) ofhapten protein conjugate in PBS. After incubation for 
18 h at 4~  plates were washed three times with PBS containing 
0.5% Tween 20. Subsequently, serum samples were placed on the 
plates using serial logarithmic dilutions and maintained for 2 h at 
4~  This was followed by the addition of goat anti-mouse IgG, 
IgG1, IgG2a, IgG2b, and IgG3 conjugated with peroxidase at a 
concentration of 1 I~g/ml (Camon, Wiesbaden, Germany); bound 
antibodies were detected by the addition of ABTS. Antibody ti- 
ters are expressed as mean OD 405 nm_  SEM. 
Statistics.  Statistical significance of differences between exper- 
imental groups was evaluated using the Wilcoxon-Mann-Whit- 
ney two sample test. Differences of.p <0.01 were considered sig- 
nificant. 
Results and Discussion 
The Murine Model.  An in vivo model was required that, 
besides easy handling, would permit ready detection of dose- 
related differences in response to experimental sensitization. 
This was achieved by painting various doses ofhapten once 
onto one ear, a site whose lymphatic drainage is clearly de- 
fined.  When  more  than  one  application was  needed,  ab- 
dominal or dorsal skin sites or both were treated in addition 
with  hapten.  The  other ear was  reserved for determining 
the attained sensitivity in a contact test. 
A  conspicuous dose dependency was  found in the ani- 
mals' reactivity to both PC1 and Ox. With PC1 as sensitizer, 
single doses in  15  Ixl olive oil/acetone (1:5)  ranging from 
1.8  X  10 -12 to 3  X  10 -5 tool were used. A  somewhat nar- 
rower dose range of Ox was examined, extending from 3.5 
X  10 -11  to 4  X  10 -6 mol. Dose-response curves were es- 
tablished first  in  BALB/c  mice  known  to  be  an  inbred 
strain  of high  responders,  and  subsequently  in  C57B1/6 
mice, an inbred strain of low responders (32, 33). 
Fig. 1, A  and B shows that very low doses did not cause 
noticeable responses upon contact testing 5 d later. Increas- 
ing the dosage stepwise gave rise to inflammatory reactions 
on  the  challenged  ear  ranging  from  threshold  sensitivity 
caused by 4.5 ~g PCI or 7.5 I~g Ox to full CHS secured by 
450  I~g PC1  or 750  I~g Ox.  Increasing the dosage further 
did not intensify the ear swelling, indicating that a plateau 
of high responsiveness had been reached. Degrees of CHS 
inducible in BALB/c  mice  were  consistently higher than 
those in C57B1/6  mice but, in principle, dose dependency 
of responses to the two sensitizers was essentially the same. 
Thus, under the conditions elaborated, two chemically un- 
related allergens exerted sensitizing capacity within a  dose 
range of two orders of magnitude, covering therein a spec- 
trum from minimal to optimal sensitization. 
The Tolerogenic Effect of Subsensitizing Doses.  Doses  that 
had been  found  to be  too low to  sensitize BALB/c mice 
and C57B1/6  mice adequately, both of PC1 and Ox, were 
assumed to be nonetheless high enough to cause tolerance. 
Proof of efficacy in this respect came from experiments in 
which those animals that had not sufficiently responded to 
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Figure 1.  (A and B) Dose-response  curves of PC1 and Ox. Panels of 
BALB/c mice and C57B1/6 nfice (five each) were painted once with des- 
ignated doses of chemicals dissolved in olive oil/acetone (1:5)  on the 
right ear (additional doses actually tested were more than those entered on 
the curves). After 7 d, the left ears were challenged with doses of 45 Ixg 
PC1 and 30 Ixg Ox and ear swelling was measured 24 h later. Values pre- 
sented are mean +  SEM. 
the first treatment were  subjected to  effectual sensitization 
on second attempt.  They were found to attain significantly 
lower  sensitivities than animals pretreated  solely with  sol- 
vent (Fig. 2). The initial stimulus from the low dose appli- 
cation was followed directly 7  d later by intentional sensiti- 
zation, avoiding a  contact testing in between lest there be 
any  influence,  in  whatever  direction,  upon  the  ongoing 
process. 
The  presence  of tolerance  must  be  proved  through  a 
subsequent attempt  to  sensitize.  This is  usually performed 
rigidly to  be most convincing. However,  it is possible for 
too  strong a  sensitizing regimen to  override  a  tolerogenic 
stimulus and thus leave a tolerogenic component unrecog- 
nized.  In the model presented here,  sensitization was  per- 
formed by a  single painting of a  dose  of allergen found to 
be adequate to secure full sensitivity but not to exceed the 
dose  required to  avoid flooding the  organism with the  al- 
lergenic hapten. 
Evidently, tolerization is precisely as dose dependent as is 
sensitization, although at a dose range three orders of mag- 
nitude lower.  The most effective tolerizing doses were  4.5 
txg PC1 and 7.5  I.tg Ox, as seen in Fig.  1, A  and B, that, at 
the  most,  had  established  threshold  sensitivity.  Still smaller 
doses applied to the skin, that is, 0.0045  p,g PCI or 0.0075 Ixg 
ear swelling (in mm x 10 -2)  C57BI/6 
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Figure 2.  Downregulating  effect of single low doses upon subsequent 
sensitization. Panels of mice  (five each) were  painted once with desig- 
nated doses of Ox on the dorsum of the right ear. After 7 d, all groups 
were sensitized by painting 750 btg Ox on the clipped abdominal wall. 
5 d later, animals were challenged on the left ear and ear swellings mea- 
sured 24 h. Values presented are mean +  SEM. With low doses of PCI 
applied epicutaneously, results were similar (not shown). 
Ox, were  essentially ineffectual in establishing tolerance by 
a  single application. However,  repeated application of low 
doses enhanced tolerance considerably. We tried several reg- 
imens, administering equal or unequal doses at various in- 
tervals, on one or on different sites; we finally determined 
the  most  effective  treatment  to  be  several  applications  of 
equal doses applied every other day on different sites. Con- 
sequently,  three  applications  of a  dose  whose  tolerogenic 
effect was insignificant when applied just once, did actually 
downregulate  subsequent  sensitization  significantly when 
duly spaced  out.  Six applications  (not shown)  rather  than 
three enhanced tolerance further and ten applications were 
still more effective (Fig. 3). Tolerance reached higher levels 
in C57B1/6  mice  (up  to  100%)  than in BALB/c  mice  (up 
to 80%), owing to genetic factors (32, 33). 
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Figure 3.  Tolerance is increased by repeated paintings of low doses ev- 
ery other day on different sites, for 3 or 10 such applications. 2 d after the 
last painting, animals were sensitized by epicutaneous application of 750 
p.g Ox and challenged on the left ear 5 d later. Values of ear thickness at 
24 h are presented in a percentage as mean •  SEM. With PCl as tolenz- 
ing chemical, results were similar (not shown). 
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tolerance was examined by carrying out the subsequent ac- 
tive sensitization after different time intervals. It was found 
that up to 24 h after application ofa tolerizing dose, no down- 
regulating effect was  demonstrable. At 36  h,  downregula- 
tion was apparent but not yet at a significant level. At 48 h 
after  the  tolerizing application,  however,  the  suppressive 
effect  was  statistically significant with  no  further  increase 
for up to 14 d  (Table 1). When the time interval between a 
single  tolerizing  application  and  subsequent  sensitization 
was  prolonged  to  21  d,  tolerance  had  meanwhile  faded. 
However, four tolerizing paintings on the right ear at weekly 
intervals  and  subsequent  sensitization  after  another  week 
extended the tolerant state to 5 wk (not shown). By cellular 
transfer  technique  as  a  tool  of investigation  it  was  con- 
firmed  that  cells  derived from  regional  (auricular)  lymph 
nodes taken at 48 h  after the tolerizing application exerted 
suppressive activity upon subsequent sensitization of the re- 
cipients with no further increase of efficacy later (data not 
shown).  These  results  demonstrate  that tolerance is estab- 
lished  more  rapidly  than  CHS.  When  sensitization  was 
tested at 48 h, the response was practically zero. 
Transfer of Tolerance.  Adoptive transfer of cells from tol- 
erant BALB/c or C57B1/6  mice into naive recipients was 
performed by intravenous injection of SC,  LNC,  or puri- 
fied T  cells from regional nodes  (Table 2).  Transfer of 107 
viable cells generally sufficed to significantly downregnlate 
contact reactions in recipients subjected to active sensitiza- 
tion within 60 rain after transfer and challenged 5 d later, as 
compared to controls receiving lymphoid cells from donors 
treated with solvent alone.  Furthermore,  recipients which 
Table 1.  Kinetics  of Tolerance Development after Painting 
of Low Doses 
Subsequent 
sensitization after  Ear swelling (in mm ￿  10 -2) 
12 h  19.2  +  3.8 
24 h  18.4 +  0.8 
36 h  12.2  +  4.5 
48 h  10.7  +  2.2* 
3d  11.0• 
4d  11.6  • 
7d  11.0•  3.7* 
14 d  11.5  •  2.8* 
21 d  16.0  +_ 4.3 
Positive control  18.2  _+ 2.9 
The tolerogenic dose of 7.5 bLg Ox was painted on the dorsum of the 
right ear of panels of BAI_B/c mice (five each) at time intervals before 
sensitization ranging from 12 h to 21  d. All groups were sensitized si- 
multaneously by painting 750  p~g Ox on the clipped abdominal wall 
and challenged 5 d later on the left ear. Values of ear swelling measured 
at 24 h are presented as mean -+ SEM. 
*p <0.01. 
Table 2.  Adoptive Transfer of Tolerance 
Donor 
Painting with  Cells transferred 
Recipient 
Challenge  Challenge 
with Ox  with PC1 
Ear swelling (in mm￿  10 -2) 
Solvent  SC  16.8  __+- 4.0  15.9  •  3.8 
1 ￿  7.5 ~g Ox  Spleen cells  6.3 +  2.1"  16.6  +  2.9 
3 ￿  7.5 p,g Ox  Spleen cells  0.9 +  1.2"  15.4  •  3.2 
1 ￿  7.5 b~g Ox  LNC  3.2 •  1.5"  16.9  +  3.6 
1 ￿  7.5 I~g Ox  Purified T cells 
(lymph node)  2.3 •  1.0"  15.3  +  4.0 
107 lymphoid cells from donors treated as indicated were injected intra- 
venously into naive recipients. Recipient BALB/c mice were double 
sensitized within 60 rain after transfer by single paintings of 750 (.Lg  Ox 
on the right side of the clipped abdominal wall and 450 Ixg PC1 on the 
left side. 5 d later, all groups were challenged with the two sensitizers 
on the right and left ear, respectively, and ear thickness was measured at 
24 h. Values presented are mean -+ SEM. 
*p <0.01. 
after  transfer  had  been  double  sensitized,  exhibited upon 
contact testing significantly downregnlated responses to the 
allergen in question but attained full CHS to the unrelated 
chemical. Thus,  the tolerant state induced by low doses of 
allergen applied onto normal skin was long-lasting (> 14 d) 
and mediated by hapten-specific suppressor cells. 
Moreover,  adoptive  transfer  experiments  revealed  that 
not only were cells derived from regional nodes effective in 
downregulating subsequent  sensitization but  also cells de- 
rived from lymph nodes draining distant skin sites and even 
distant nmcosal areas (Fig. 4). However, the degree of trans- 
fer from the different sources was not equal, being highest 
in cells from regional nodes, somewhat lower in cells from 
inguinal nodes, and lowest in cells from mesenteric nodes, 
irrespective of whether the transferred cells had been har- 
vested on day 2 or 5 after tolerization. 
The same technique also showed that the application of 
sensitizing  doses  induced  generation  of  suppressor  cells, 
which however, were detectable only at 48  h  after sensiti- 
zation. Of viable cells, 10  v were as effective in downregu- 
lating subsequent sensitization as 10-fold as many cells (Fig. 
5). In contrast, transfer of cells harvested on day 5 after sen- 
sitization showed no suppressive activity (not shown). 
Sensitivity to Cy.  The  suppressor cells that  were  found 
to  be present surprisingly early and  that  were  widely dis- 
tributed  among  peripheral lymphatic  organs,  were  tested 
for sensitivity to Cy.  This drug is known  to act on B  cells 
and  a  population of shortqived,  rapidly proliferating sup- 
pressor T  cells (34,  35).  Both BALB/c and C57B1/6  mice 
were treated with Cy (200 mg/kg, i.p.) 2 d before epicuta- 
neous application of either tolerizing or sensitizing doses or 
only the solvent. Compared with animals that had not been 
pretreated  with  Cy,  the  tolerizing effect  of low  allergen 
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with 7.5 pg oxazolone 
2 days prior to transfer 
1 x 107 LNC auricular 
1 x 107 LNC inguinal 
1 x 107 LNC mesenteric 
5 days prior to transfer 
1 x 107 LNC auricular 
1 x 107 LNC inguinal 
1 x 107 LNC mesenteric 
with solvent 
1 x 107 LNC auricular 
C57BI/6 
i  i 
I  iJ 
I  ￿9 
I 
II 
!  !  i 
I 
I 
0  20  40  60  80  100 
* p < 0.005  ear swelling  (in %) 
Figure 4.  Comparison of transfer capability of LNC derived from dif- 
ferent sources. Equal numbers of viable cells (107) derived from auricular 
(regional),  from inguinal (nonregional), and from mesenteric (mucosal) 
lymph nodes were adoptively transferred.  The recipients were sensitized 
within 60 rain after transfer  by a single painting of 750 Ixg Ox on the 
right ear and challenged 5 d later on the left ear. Values of ear thickness 
measured at 24 h are presented in a percentage as mean -+ SEM. 
i.p. injection 
Cy 
Cy 
Cy 
painted with 
solvent 
7.5 pg Ox 
750 #g Ox 
PBS  solvent 
PBS  7.5 pg Ox 
PBS  750 pg Ox 
-~" p < 0.005 
C57BI/6 
0  5  10  15  20  25  30  35 
ear swelling (in mm x 10  -2) 
Figure 6.  Cy blocks generation of suppressor  cells. Panels of C57B1/6 
mice (six each) were given 200 mg/kg Cy, i.p., and subsequently painted 
on the right ear with 750 I~g Ox (sensitizing dose), or 7.5 I~g Ox (toleriz- 
ing dose),  or solvent alone.  After 2 d,  all groups  (hatched bars) including 
controls left untreated with Cy but otherwise painted equally (solid bars) 
were sensitized by a single epicutaneous application of 750 txg Ox on the 
clipped abdominal wall and challenged 5 d later on the left ear. Values of 
ear  thickness measured at  24 h  are  presented as  mean -+  SEM.  With 
BALB/c mice treated similarly, results were comparable (not shown). 
doses  was  completely  annihilated  (Fig.  6).  Moreover,  the 
degree of CHS  attained upon subsequent sensitization of all 
experimental groups was found to be considerably enhanced 
as compared to control animals left untreated with Cy. Ob- 
viously,  through  elimination  of precursor  cells before  ex- 
perimental  tolerization and sensitization,  the generation  of 
hapten-specific  suppressor  cells  was  prevented  in  the  Cy- 
treated groups and thereby,  the induction of tolerance pre- 
cluded, whereas sensitization was improved. 
Donors painted with 750 pg oxazolone 
2  days prior to transfer 
LNC  (1.0 x  10  z) 
LNC  (2.5 x  107) 
LNC  (5.0 x  107) 
LNC  (10 x  10  z) 
7,5 pg  Ox 
750/~g  Ox 
0 
"~ p <  0.005 
C57Bl/6 
2  4  6  8  10  12  14  16  18 
ear swelling (in mm x 10 -2) 
Figure 5.  Sensitization normally includes generation of suppressor cells. 
LNC  (regional)  were taken from donors that 2  d previously had been 
painted once on the fight ear with 750 ~g Ox, a dose that regularly  in- 
duces  CHS.  Different numbers of viable ceils ranging from  107 to  108 
were adoptively transferred into panels of C57B1/6 mice (six each). The 
recipients  (hatched bars) including  controls  (solid bars) were  sensitized 
within 60 rain after  transfer  by a single painting of 750  txg Ox on the 
fight ear and challenged 5 d later on the left ear. A single painting of a 
sensitizing  dose generated T  suppressor  cells within 2  d.  Increasing  the 
number of cells transferred  did not heighten the degree of tolerance. Val- 
ues presented are mean -+ SEM. 
In a further experiment along this line,  animals of both 
strains were treated with Cy and sensitized to Ox 2 d later. 
Upon challenge, the usual test dose (30 p,g Ox) was com- 
pared with two log10 doses farther down  (Table 3).  Upon 
contact testing it became apparent that the Cy-treated ani- 
mals responded to a  test dose that was  10-fold below the 
dose to which untreated animals used to respond. Thus, re- 
moving suppressor cells from the  normal pool of hapten- 
specific effector cells by Cy treatment revealed suppression 
to be a usual constituent of sensitization as a whole. 
Suppression of Antibody Production.  To  see whether  sup- 
pressor  cell activity in our  model  would  also  involve sup- 
pression  of antihapten  antibody  production,  10  C57BI/6 
mice were  rendered tolerant to  Ox  by painting 7.5  Ixg Ox 
10 times every other day on different abdominal and dorsal 
skin sites.  Similarly,  10 control animals were painted solely 
Table  3.  Cy Enhances Sensitivity to Contact  Testing 
Painted  Challenge  Ear swelling 
i.p. injection of  with  with Ox  (in mm X  10 -2) 
/~g 
PBS  750 I~g Ox  30.0  14.5  +  3.4 
PBS  750 Ixg Ox  3.0  2.3 -+  1.5 
PBS  750 p,g Ox  0.3  0.0  +- 0.0 
Cy  750 Ixg Ox  30.0  28.6 +  3.1 
Cy  750 p,g Ox  3.0  13.1  +-- 3.4 
Cy  750 txg Ox  0.3  2.6  -+ 2.6 
Panels of C57B1/c mice (six each) were treated with PBS or 200 I~g/kg 
Cy and subsequently sensitized by painting 750 mg Ox on the fight ear. 
Upon contact testing,  Cy-treated animals exhibited a 10-fold higher sen- 
sitivity indicating that before sensitization, generation of suppressor cells 
was blocked￿9 
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Figure 7.  Painting subsensitizing doses of 
Ox dimishes the production of anti-Ox IgG 
antibodies.  C57B1/6  mice  were  painted 
with  7.5  I~g Ox or solvent 10  times (five 
each). Two d after the last appfication, both 
groups were sensitized with 750 I~g Ox and 
challenged  5  d  later.  A  negative  control 
group  (n =  5)  was pretreated with solvent 
and subsequently sensitized to the irrelevant 
hapten  PC1.  Serum samples were  collected 
19 d a~er sensitization and levels of anti-Ox 
total  IgG,  lgG1,  and  IgG2a  were  deter- 
mined  by  ELISA.  Antibody  titers  are  ex- 
pressed as mean OD 405 nm+  SEM. 
with the solvent.  2  d  after the last paintings, both groups 
were given a single sensitizing painting of 750  Izg Ox on 
the right ear and ear challenged 5 d later on the left ear. As 
expected,  mice  pretreated  with  10  subsensitizing  doses 
were  completely tolerant;  the positive control group was 
well  sensitized  (data  not  shown).  Another  group  of mice 
was sensitized to PC1 instead for "negative" control. Half of o 
the animals were bled on day 12 after the sensitizing paint- 
ing, the other half on day 19. 
Fig.  7 shows that in tolerant mice, hapten-specific anti- 
bodies were significantly diminished as compared to those 
in sensitized mice. The titers measured in sera of tolerant 
animals  were  at  the  same low level  as  those  in  negative 
controls sensitized to PC1.  This was also found in the sub- 
classes  IgG1  (Th2 response)  and IgG2a (Thl  response), as 
well as in the subclasses  IgG2b and IgG3 (not shown). An- 
tibody production measured on day 12 was not significantly 
different from that on day 19. Similar results were obtained 
when BALB/c mice were used,  although suppression was 
not as complete. With PC1 as tolerizing or sensitizing agent, 
antibody titers measured in both strains were generally lower. 
Depletion of T Cell Phenotypes.  To further characterize the 
suppressor cells, lymphoid cells from auricular lymph nodes 
draining the site of application ofa tolerizing dose were de- 
pleted in vitro by mAb to  either L3T4  or Lyt2 antigens. 
The  antibody-coupled  cells  were  removed  by magneto- 
beads coupled with sheep anti-rat  IgG. The residual cells 
were  adoptively  transferred  into  naive  animals  with  107 
cells each and compared to adoptive transfer of 107 cells of 
the total cell pool. After sensitization within  60 rain after 
transfer and elicitation 5 d later, readings of ear swelling re- 
vealed  that  tolerance  was  transferred  by the  fraction  de- 
pleted of L3T4 cells, whereas the fraction depleted of Lyt2 
cells did not downregnlate subsequent sensitization (Fig. 8). 
With  PCI as  tolerizing  agent,  results  were  essentially  the 
I 
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same  (not  shown)  in  experiments with  C57B1/6  mice as 
donors and recipients.  Thus, the T  cells exerting suppres- 
sion in  our model of low zone  tolerance were shown  to 
express the Lyt2  + determinant.  There were no hints indi- 
cating that other T  cells or other types of cells would par- 
ticipate in the suppression. The Lyt2  + subset of the mouse 
is considered equivalent to CD8 + T  cells in humans. These 
T  cells were in our model effective on immune cells, which 
Adoptive  Transfer of 
LNC 
LNC  +  anti-L3T4 
LNC  +  anti-Lyt2 
*  p  <  0.005 
Figure  8. 
7.5 pg OX  ] 
solvent 
0 
BALB/c 
5  10  15  20  25  30 
ear swelling  (in mm x 10-2) 
Adoptive transfer of in vitro-depleted LNC  derived from 
tolerant  donors.  70  BALB/c  mice  were  tolerized  by  six  consecutive 
paintings of 7.5  p~g Ox every other day on different sites, with the last 
two apphcations painted simultaneously on both ears. After 2 d, the ani- 
mals were killed and the auricular lymph nodes of both sides taken. Cells 
derived from these nodes were depleted in vitro by mAbs to either L3T4 
or Lyt2 antigens, and the antibody-coupled cells were removed by mag- 
netobeads coupled with sheep anti-rat IgG. Equal numbers of viable cells 
(107)  of the nondepleted  original  cell  pool  and of both  fractions were 
adoptively transferred into  panels of naive BALB/c mice  (seven each). 
The recipients (hatched  bars),  and also tolerized and solvent-treated con- 
trols (solid  bars),  were sensitized within 60 rain after transfer by a single 
painting of 750 ~g Ox on the right ear and challenged 5 d later on the left 
ear. With C57B1/6 mice treated similarly with PC1, results were compa- 
rable (not shown). is characteristic for efferent suppressors (9). They are equiv- 
alent to the third subset of the murine suppressor T  cell cir- 
cuit, termed Ts  3 cell, that is highly sensitive to Cy, antigen 
specific, and  expresses the  Lyt2 §  phenotype  (9).  The  Ts  3 
type was  originally described by Sy et  al.  (36)  and  desig- 
nated  Ts-aux  (auxiliary suppressor cells)  as being  essential 
for suppression of CHS. 
Patterns of  Cytokine  Production after In  Vitro Activation. 
In light of the  present  knowledge  of immunosuppression 
by  T  cells  (11)  it  was  mandatory  to  determine  whether 
LNC from tolerant mice would, upon appropriate stimula- 
tion,  produce  a  different pattern  of cytokine activity than 
LNC  from  sensitized mice.  Regional  lymph  nodes  were 
taken  from  tolerized, sensitized,  and  solvent-treated mice 
of both  strains,  and  disaggregated.  LNC  were  then  incu- 
bated  with  SC  that  had  been  haptenized  in  vitro  with 
TNBS  and  subsequently  irradiated. After coculturing  the 
cells for 3 d, the supernatants were tested for Th2 cytokines 
as well as Thl  cytokines. It was found (Table 4) that LNC 
derived from tolerant mice produced predominantly IL-4, 
IL-5, and  IL-10, but no  detectable IL-2 and little IFN-',/. 
Conversely, LNC  from  sensitized mice secreted preferen- 
tially  IL-2  and  IFN-y,  but  little  IL-4,  IL-5,  and  IL-10. 
Moreover,  BALB/c mice  (high responders)  produced sig- 
nificantly more IL-2 than  C57B1/6  mice  (low responders) 
but less IL-4, IL-5, and IL-10. 
We did not investigate the entire spectrum of cytokine 
production  but  rather  concentrated  on  the  critical  cyto- 
kines  that  characterize  the  two  patterns  (37).  Originally, 
they  were  discovered by  Mosmann  and  co-workers  (12, 
13)  in  a  panel  of murine  helper T  cell clones,  that  is,  in 
CD4 + T  cells. Some years later it was shown that alloreac- 
tive murine CD8 §  T  cell clones also produce the Thl  pat- 
tern:  they secrete IFN-y and lymphotoxin similar to  Thl 
clones but IL-2 at significantly lower levels (14). However, 
synthesis oflL-4 and IL-5 could not be detected. But even- 
tually it was reported that CD8 + T  cells can be induced to 
produce IL-4 as well (15). When such cells were primed in 
vitro with immobilized antibodies to CD3  (8 chain of the 
TCR  complex) in the presence oflL-2 and IL-4 they were 
as  active  in  producing  IL-4  as  similarly primed  CD4 +  T 
cells. Thus,  naive CD8 + T  cells also differentiate upon ap- 
propriate  stimulation  into  functional  subsets  that  act  like 
the two helper T  cell subsets. 
The sole variable in our model is the dose of hapten ap- 
plied.  Low  doses  initiate an  immune  response  that  is  en- 
tirely different from that initiated by high doses, suggesting 
compartmentalization of functional subsets of T  cells. We 
have  found  that  LNC  ceils from  mice  tolerant to  contact 
sensitizers produced preferentially type 2 cytokines, whereas, 
LNC from sensitized mice produced predominantly type 1 
cytokines.  It  must  be  emphasized  that  the  LNC  derived 
from  our  tolerant  mice  are  not  exclusively composed  of 
CD8 +  suppressor  cells, just  as LNC  from  sensitized mice 
do not solely contain CD4 + Thl  cells (38) but include reg- 
ularly suppressor cells, as shown  by pretreating mice  with 
Cy (Fig. 6).  Nonetheless, a  switch in cytokine production 
was obvious from a typical Thl  response in sensitized mice 
to a Th2 response in tolerant mice. However, on the B  cell 
level such  a switch was  not detectable. Either the method 
used was  not  sensitive enough  or antibody production  to 
these particular antigens was indeed completely suppressed, 
as was delayed hypersensitivity. The differences in produc- 
ing the respective cytokines among the two  strains  (Table 
4) appear to reflect their different genetic backgrounds (32) 
and explain, in part, their diverse responses to tolerization 
and  sensitization.  This  is  the  first  demonstration,  to  our 
knowledge, that suppressor cells generated in low dose tol- 
erance  to  contact  allergens  are  CD8 +  Th2-1ike  T  cells. 
Through  their production and secretion of Th2  cytokines, 
they exert anti-inflammatory effects that counteract subse- 
quent attempts to sensitize. 
Obviously, CD8 + Th2-1ike ceils have a different signifi- 
cance  in  tolerance  to  contact  allergens than  in  infectious 
disease. Unresponsiveness to intracellular pathogens such as 
Mycobacterium leprae results in  decreased resistance.  In fact, 
Table 4.  Cytokine  Production of LNC  from Tolerized and Sensitized Mice 
Painted with  IL-2  IFN-',/  IL-4  IL-5  IL-  10 
BALB/c 
C57B1/6 
pg/ml 
Solvent  <10.0  <1.0  <1.0  <15.0  <1.0 
4.5 p,g  <10.0  60.2  _+  10.5  145.0  +  37.5  413.8  +  99.6  532.0  -+ 45.1 
450 btg  433.1  +  56.7  4,304.8  +  105.4  10.8  _+ 9.9  50.5  +  21.0  25.8 +  10.1 
Solvent  < I 0.0  < 1.0  < 1.0  < 15.0  < 1.0 
4.5 b~g  <10.0  <10.0  252.9 +  56.8  711.5  -4- 92.9  1,415.3  +  89.5 
450 I~g  120.9  +  23.6  473.4  -+ 49.6  12.8  +  9.5  43.2 +  28.9  24.6 +  12.9 
Panels (six each) of both mouse strains were painted with solvent solely or either tolerized (six consecutive paintings of 4.5 b~g PCI every other day 
on different sites, with the last two applications painted simultaneously on both ears) or sensitized (single painting of 450 ~g PCI on one ear). 2 d af- 
ter the last tolerizing application or 5 d after the sensitizing painting, respectively, mice were killed and their regional lymph nodes taken. After me- 
chanical disaggregation, LNC from these various groups were separately cocultured for 3 d with TNBS-haptenized and irradiated normal SC. Super- 
natants were subsequently harvested and kept frozen for further use. Denoted cytokines were measured in samples of the supernatants by sandwich 
ELISAs. Values presented are mean •  SEM of two separate experiments. 
766  CD8 + Th2-1ike Cells Mediate Tolerance to Contact Allergens human  CD8 +  Th2-like  cells  were found to be present in 
skin lesions of the susceptible lepromatous form of leprosy 
that contain large numbers ofbaciUi (17).  In contrast, CD4 + 
Thl  cells  secrete IFN-~/preferentially and are the predom- 
inant cell type present in the resistant tuberculoid lesions of 
leprosy that  contain  few bacilli.  In a  mouse  model  using 
transgenic mice, it was shown more recently that an IL-4- 
dependent switch to IL-5 production in virus-specific CD8 + 
T  cells  delayed viral clearance from the murine host (21). 
Low zone tolerance to contact allergens has certain fea- 
tures in common with inhalation and oral tolerance to non- 
replicating  antigens.  In an experimental  model developed 
for eliciting immune responses to low doses of inhaled OVA 
repeated exposures to this antigen rendered rats tolerant to 
subsequent  parental  immunization  with  OVA.  This  toler- 
ant  state  was  selective  for  the  IgE  antibody  isotype  and 
could be transferred  adoptively with CD8 + T  cells.  How- 
ever,  the  cells  mediating  this  particular  state  of tolerance 
were found to secrete upon in vitro activation high levels 
of IL-2 and IFN-% that is, type 1 cytokines (39). 
Different  immunologic  mechanisms  appear  to  underly 
oral tolerance depending on dosage and frequency of feed- 
ing  (19).  Low dose  antigen  feeding generated  active  sup- 
pression by T  cells producing IL-4, IL-10, and TGF-~3.  In 
contrast, high dose feeding enhanced the secretion of both 
Th2 and Thl cytokines. Moreover, clonal energy was found 
to be involved in high dose tolerance, and in Peyer's patches 
antigen-reactive Thl  and Th2 cells were deleted by activa- 
tion-induced apoptosis (40). 
We  are  inclined  to  believe  that  tolerance  to  potential 
contact  sensitizers  might  have  pathophysiological  impor- 
tance.  It could represent a fundamental mechanism dealing 
with  small amounts  of a  foreign substance penetrating the 
skin.  Such  a  mechanism  would  prevent  an  inflammatory 
response  that otherwise  would be inevitable  unless  a mas- 
sive  amount  of that  substance  were  to  exceed  the  allow- 
ance. Tolerance would then be broken and contact derma- 
titis  would  result.  "Contact  tolerance"  seems  to  apply  to 
this type of peripheral hyporesponsiveness and we take the 
risk of proposing the term. 
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